AGÕæÈ˹ٷ½

Form 4 shows that CEO & Co-CIO David L. Finkelstein disposed of 50,000 Annaly Capital Management (NLY) common shares on 08/04/2025.

• Weighted-average price: $20.79 (range $20.57-$20.93).
• Sale executed under a Rule 10b5-1 plan adopted 05/16/2024 for tax and estate planning purposes.
• Post-sale direct holding: 743,430 shares, which includes dividend-equivalent units (DEUs). The transaction reduced his direct position by roughly 6%.

No derivative transactions were reported. The filing is a routine Section 16 disclosure; no earnings or operational data were included.

Because the sale was pre-scheduled, it lessens concerns about adverse insider sentiment, yet large disposals by top executives can still be interpreted cautiously by investors. Further insider activity should be monitored for trend confirmation.

MicroStrategy Incorporated filed a Form 8-K on 31 Jul 2025 to furnish a press release (Exhibit 99.1) containing its financial results for the quarter ended 30 Jun 2025. The actual revenue, earnings and margin figures are not included in the filing and are therefore not deemed “filedâ€� under the Exchange Act.

Separately, under Item 8.01, the board declared a $0.80 monthly cash dividend on the Variable Rate Series A Perpetual Stretch Preferred Stock (ticker STRC). The dividend covers the accrual period beginning 29 Jul 2025—STRC’s issuance date—and will be paid on 31 Aug 2025 to shareholders of record as of 15 Aug 2025.

Keurig Dr Pepper Inc. (KDP) filed a Form 144 indicating that the Robert J. Gamgort 1999 Trust intends to sell 208,000 common shares through Morgan Stanley Smith Barney on or about 29 Jul 2025. At an assumed market price of roughly $32.95 per share, the aggregate value is $6.86 million. KDP has â‰�1.36 billion shares outstanding, so the proposed sale represents â‰�0.015 % of total shares.

The trust—associated with KDP’s Executive Chairman Robert Gamgort—has already executed two sales under a Rule 10b5-1 trading plan within the past three months:

• 1 May 2025: 208,000 shares for $7.10 million
• 2 Jun 2025: 208,000 shares for $6.89 million

No purchase-price debt, material adverse information, or non-public information is indicated, and the filer affirms compliance with Rule 144 and 10b5-1 requirements. While the dollar amount is notable, the percentage of float is immaterial and does not, by itself, signal a shift in company fundamentals.

flyExclusive, Inc. (NYSE American: FLYX) filed an 8-K (Item 8.01) announcing it has waived the lock-up that restricted EG Sponsor LLC from selling 5.625 MM Class A shares and 4.333 MM warrants until 27 Dec 2026. The waiver, executed 25 Jul 2025 and effective immediately, is intended to clear a March 2025 Russell 2000 rule that bars index inclusion while such restrictions are in place. Management believes Russell inclusion would raise trading volume, liquidity and enhance access to its at-the-market program.

The Audit & Risk Committee and the full Board (with interested directors Gregg Hymowitz and Gary Fegel recused) approved the waiver in line with company policy. All other terms of the 2021 Letter Agreement between the Company and EG Sponsor LLC remain unchanged.

No financial metrics were disclosed; the filing is limited to governance actions surrounding the share release and potential index listing.

Block, Inc. (ticker: XYZ) filed a Form 144 to notify the SEC of an intended sale of 2,800 shares of its common stock. The shares are to be sold through Morgan Stanley Smith Barney LLC on the NYSE around 15 July 2025. At the stated aggregate market value of $190,568, the proposed sale equals roughly 0.0005 % of the company’s 615.0 million shares outstanding, indicating a very limited dilution effect.

The securities being sold were originally received as restricted-stock grants on three separate dates�02/20/2024 (1,442 shares), 11/20/2023 (961 shares) and 01/03/2023 (397 shares). No cash was paid at acquisition, implying the grants were part of equity-based compensation.

Over the last three months, the same reporting person executed nine open-market sales totaling 22,918 shares for gross proceeds of approximately $1.45 million. Even when combined with the new notice, total insider sales remain immaterial relative to Block’s share count and typical daily trading volume.

Form 144 requires the insider to certify that they possess no undisclosed material adverse information and, if relying on a Rule 10b5-1 plan, to disclose the plan-adoption date. No such plan date is provided in the filing.

Bentley Systems, Incorporated (BSY) has filed a Form 144 indicating that an insider intends to sell up to 20,313 common shares through broker Morgan Stanley Smith Barney LLC. The proposed sale, valued at approximately $1.15 million, is scheduled on or about 07 July 2025 on the NASDAQ exchange. The shares were originally acquired on 01 April 2022 via restricted stock unit (RSU) vesting.

The same account has already sold 19,156 shares on 03 July 2025 for gross proceeds of $1.05 million, as disclosed in the past-three-month sales table. The filer certifies compliance with Rule 144 and affirms no undisclosed material information. A Rule 10b5-1 trading plan appears to be in place, as the prior sale is labelled â€�10b5-1 Sales.â€�

No earnings metrics or operational updates accompany this filing; it is strictly a notice of intended share disposition.

Form 4 filing overview

On July 8, 2025 Agios Pharmaceuticals, Inc. (AGIO) granted Director Jay T. Backstrom two equity awards:

• 23,393 non-qualified stock options at an exercise price of $36.28, vesting 25 % after one year and monthly thereafter through July 2029; expiration July 8, 2035.
• 4,341 restricted stock units (RSUs) convertible into one share each, vesting in three equal annual tranches starting July 8, 2026.

After the grant, Backstrom beneficially owns 23,393 options and 4,341 RSUs, all held directly.

The transaction is coded “A,� indicating a company-issued award rather than an open-market purchase, and no shares were sold. No financial performance metrics or strategic disclosures are included, making this a routine compensation event that modestly aligns the director’s incentives with shareholder interests.

Telos Corporation (NASDAQ: TLS) filed an 8-K announcing the appointment of Donald Joseph “DJ� Terreri, 43, as Controller, Chief Accounting Officer and principal accounting officer, effective 8 July 2025. Terreri will report to CFO Mark Bendza and receive a $285,000 base salary, standard benefits, eligibility for the annual bonus plan and equity awards.

Terreri brings more than a decade of senior accounting experience: Regional Finance Director for CBRE’s Government & Defense business (2024-2025), Corporate Controller for J&J Worldwide Services (2022-2024), and Principal Accounting Officer at ICF International (NASDAQ: ICFI) (2020-2022). Earlier roles include Controller at Privia Health and multiple corporate accounting positions at Discovery Communications. He is a Certified Public Accountant and holds a B.S. in Accounting & Information Systems from Virginia Tech.

The filing is limited to the leadership change; it contains no financial performance data or strategic transaction disclosures. For investors, the news signals reinforcement of Telos� financial reporting function but is unlikely to have a near-term earnings impact.